Fuxing Xiong

489 total citations
7 papers, 413 citations indexed

About

Fuxing Xiong is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fuxing Xiong has authored 7 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fuxing Xiong's work include Pancreatic and Hepatic Oncology Research (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Advanced Chemical Sensor Technologies (2 papers). Fuxing Xiong is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Advanced Chemical Sensor Technologies (2 papers). Fuxing Xiong collaborates with scholars based in China. Fuxing Xiong's co-authors include Geng Song, Zhendong Chen, Hu Liu, Yueyin Pan, Kangsheng Gu, Guobing Xu, Tao Qin, Guoping Sun, Guoping Sun and Qi Song and has published in prestigious journals such as Cancer Epidemiology Biomarkers & Prevention, Lung Cancer and Annals of Translational Medicine.

In The Last Decade

Fuxing Xiong

7 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fuxing Xiong China	7	256	111	111	94	52	7	413
E Travaglio Italy	6	248 1.0×	130 1.2×	80 0.7×	50 0.5×	77 1.5×	9	386
L. F. Wiggins United Kingdom	11	88 0.3×	105 0.9×	48 0.4×	42 0.4×	11 0.2×	25	352
Shigeyuki Oguri Japan	16	318 1.2×	280 2.5×	228 2.1×	35 0.4×	4 0.1×	28	684
Xizhong Shen China	9	154 0.6×	123 1.1×	98 0.9×	21 0.2×	7 0.1×	15	375
Taina Palosaari Italy	12	87 0.3×	134 1.2×	15 0.1×	20 0.2×	3 0.1×	19	449
Anita Sztojkov‐Ivanov Hungary	13	56 0.2×	144 1.3×	117 1.1×	6 0.1×	6 0.1×	26	480
Futian Han United States	8	195 0.8×	117 1.1×	60 0.5×	28 0.3×	4 0.1×	9	365
Yangsun Kim South Korea	12	54 0.2×	196 1.8×	152 1.4×	23 0.2×	1 0.0×	21	376
Kyungah Suh United States	9	67 0.3×	234 2.1×	71 0.6×	14 0.1×	2 0.0×	18	382

Countries citing papers authored by Fuxing Xiong

Since Specialization

Citations

This map shows the geographic impact of Fuxing Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuxing Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuxing Xiong more than expected).

Fields of papers citing papers by Fuxing Xiong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuxing Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuxing Xiong. The network helps show where Fuxing Xiong may publish in the future.

Co-authorship network of co-authors of Fuxing Xiong

This figure shows the co-authorship network connecting the top 25 collaborators of Fuxing Xiong. A scholar is included among the top collaborators of Fuxing Xiong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuxing Xiong. Fuxing Xiong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Huang, Nana, Chenchen Zhao, Wei Huang, et al.. (2022). Anlotinib plus nab-paclitaxel/gemcitabine as first-line treatment prolongs survival in patients with unresectable or metastatic pancreatic adenocarcinoma: a retrospective cohort. Annals of Translational Medicine. 10(6). 294–294. 8 indexed citations

2.

Huang, Wei, et al.. (2022). Effectiveness and safety of camrelizumab combined with chemotherapy in nonsquamous nonsmall cell lung cancer as the second-line therapy. Journal of Cancer Research and Therapeutics. 18(2). 576–580. 6 indexed citations

3.

Huang, Nana, Chenchen Zhao, Congjun Zhang, et al.. (2022). Safety and efficacy of sintilimab combination therapy for the treatment of 48 patients with advanced malignant tumors. Translational Cancer Research. 11(1). 252–261. 9 indexed citations

4.

Chen, Wenjun, Xiaoqiu Li, Chenchen Zhao, et al.. (2019). Clinical efficacy analysis of Osimertinib treatment for a patient with leptomeningeal metastasis of EGFR+ non-small cell lung cancer without the T790M mutation. Annals of Palliative Medicine. 8(5). 525–531. 11 indexed citations

5.

Chi, Yihebali, Hao Yu, Zhenzhong Wang, et al.. (2013). An open-labeled, randomized, multicenter phase IIa study of gambogic acid injection for advanced malignant tumors. Chinese Medical Journal. 126(9). 1642–1646. 88 indexed citations

6.

Qin, Tao, Hu Liu, Qi Song, et al.. (2010). The Screening of Volatile Markers for Hepatocellular Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 19(9). 2247–2253. 76 indexed citations

7.

Song, Geng, Tao Qin, Hu Liu, et al.. (2009). Quantitative breath analysis of volatile organic compounds of lung cancer patients. Lung Cancer. 67(2). 227–231. 215 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact